![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/20 | (2006.01) |
A61K 9/28 | (2006.01) | ||
A61K 31/7068 | (2006.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 1/18 | (2006.01) | ||
A61P 7/00 | (2006.01) | ||
A61P 15/08 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/02 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 3782611 |
(13) | Kind of document | T |
(96) | European patent application number | 20201105.2 |
Date of filing the European patent application | 2009-05-14 | |
(97) | Date of publication of the European application | 2021-02-24 |
(45) | Date of publication and mention of the grant of the patent | 2022-07-06 |
(46) | Date of publication of the claims translation | 2022-10-10 |
(30) | Number | Date | Country code |
5360908 P | 2008-05-15 | US | |
20114508 P | 2008-12-05 | US | |
15787509 P | 2009-03-05 | US |
(72) |
ETTER, Jeffrey B , US
LAI, Mei , US
BACKSTROM, Jay T , US
|
(73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Citidino analogų peroralinės kompozicijos ir jų naudojimo būdai |
ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF |
Payment date | Validity (years) | Amount | |
2025-04-02 | 17 | 347.00 EUR |
2026-05-14 |